C L Corless
Overview
Explore the profile of C L Corless including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben-Ami E, Barysauskas C, von Mehren M, Heinrich M, Corless C, Butrynski J, et al.
Ann Oncol
. 2016 Jul;
27(9):1794-9.
PMID: 27371698
Background: This investigator-initiated trial provided the justification for the phase III GRID study resulting in worldwide regulatory approval of regorafenib as a third-line therapy for patients with metastatic gastrointestinal stromal...
2.
Kang B, Slosberg E, Snodgrass S, Lebedinsky C, Berry D, Corless C, et al.
Clin Pharmacol Ther
. 2015 Mar;
98(2):124-6.
PMID: 25810246
Early-phase clinical development in oncology has evolved dramatically with the deciphering of the human genome in 2004. Genomic analysis and the tools identifying genetically disrupted pathways within a patient's tumor...
3.
Bains T, Heinrich M, Loriaux M, Beadling C, Nelson D, Warrick A, et al.
Leukemia
. 2012 Mar;
26(9):2144-6.
PMID: 22425895
No abstract available.
4.
Dumont A, Rink L, Godwin A, Miettinen M, Joensuu H, Strosberg J, et al.
Ann Oncol
. 2011 Oct;
23(5):1335-1340.
PMID: 21994214
Background: Gastrointestinal stromal tumors (GISTs) and desmoid tumors (DTs) are two rare mesenchymal tumor. Anecdotal reports of individuals with both diseases led us to make the hypothesis that the association...
5.
Emile J, Brahimi S, Coindre J, Bringuier P, Monges G, Samb P, et al.
Med Oncol
. 2011 Sep;
29(3):1765-72.
PMID: 21953054
Gastrointestinal stromal tumors (GISTs) are the most common human sarcoma. Most of the data available on GISTs derive from retrospective studies of patients referred to oncology centers. The MolecGIST study...
6.
ORourke R, White A, Metcalf M, Olivas A, Mitra P, Larison W, et al.
Diabetologia
. 2011 Mar;
54(6):1480-90.
PMID: 21400042
Aims: Hypoxia has been implicated as a cause of adipose tissue inflammation in obesity, although the inflammatory response of human adipose tissue to hypoxia is not well understood. The goal...
7.
Day F, Desai J, Corless C, Heinrich M, Zalcberg J
Med Oncol
. 2010 Aug;
28 Suppl 1:S162-4.
PMID: 20799000
Gastrointestinal stromal tumors lacking mutations in KIT or PDGFRα are known as wild type (WT) and are less responsive to imatinib. These WT tumors are hypothesized to be dependent on...
8.
Pavcnik D, Uchida B, Timmermans H, Corless C, Keller F, Rosch J
Minim Invasive Ther Allied Technol
. 2010 Feb;
9(3-4):287-92.
PMID: 20156026
The purpose of this paper is to present in vitro and in vivo experimental evaluation of a new, artificial, bicuspid, aortic and venous valve. Valves were constructed from square stents...
9.
Liegl B, Kepten I, Le C, Zhu M, Demetri G, Heinrich M, et al.
J Pathol
. 2008 Jul;
216(1):64-74.
PMID: 18623623
Most GIST patients develop clinical resistance to KIT/PDGFRA tyrosine kinase inhibitors (TKI). However, it is unclear whether clinical resistance results from single or multiple molecular mechanisms in each patient. KIT...
10.
Agarwal A, Eide C, Harlow A, Corbin A, Mauro M, Druker B, et al.
Leukemia
. 2008 May;
22(12):2269-72.
PMID: 18509354
No abstract available.